Status:
COMPLETED
Ghrelin - A Possible Opportunity to Improve Appetite
Lead Sponsor:
Göteborg University
Collaborating Sponsors:
Swedish Cancer Foundation
Medical Research Council
Conditions:
Cancer
Eligibility:
All Genders
40-80 years
Phase:
PHASE3
Brief Summary
The study is designed to evaluate whether ghrelin treatment can improve appetite in weight losing cancer patients.
Detailed Description
Randomized study with follow up evaluations each month until preterminal state. Cancer patients will be randomised to either high dose or low dose of active treatment given as daily injection.
Eligibility Criteria
Inclusion
- Weight loss
Exclusion
- Diabetes
Key Trial Info
Start Date :
October 1 2003
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
July 1 2008
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT00681486
Start Date
October 1 2003
End Date
July 1 2008
Last Update
August 21 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of surgery, Sahlgrenska University Hospital
Gothenburg, Sweden, 413 45